VEGF Targeting Agents in Ovarian Cancer

kod QR

VEGF Targeting Agents in Ovarian Cancer

None

Zapisane w:

Opis bibliograficzny
Główni autorzy:	Mabuchi, Seiji, Wakabayashi, Atsuko, Kimura, Tadashi
Format:	Elektroniczne Rozdział
Język:	angielski
Wydane:	IntechOpen 2012
Hasła przedmiotowe:	Health Sciences
Dostęp online:	https://www.intechopen.com/chapters/28409
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy

Autotaxin – A Target for the Treatment of Drug-Resistant Ovarian Cancer?
od: King-Underwood, John, i wsp.
Wydane: (2012)

Beyond VEGF: The NOTCH and ALK1 Signaling Pathways as Tumor Angiogenesis Targets
od: Nolan-Stevaux, Olivier, i wsp.
Wydane: (2012)

The Role of VEGF in the Process of Neovasculogenesis
od: Sobczyńska-Rak, Aleksandra
Wydane: (2012)

Inflammation and Ovarian Cancer
od: Macciò, Antonio, i wsp.
Wydane: (2012)

Myeloid-derived suppressor cells and their role in gynecological malignancies
od: Seiji Mabuchi, i wsp.
Wydane: (2018-08-01)

Neoadjuvant Chemotherapy in Ovarian Cancer
od: Singh, Jasmeet Chadha, i wsp.
Wydane: (2012)

Epidemiology and Etiology of Ovarian Cancer
od: Montes, Ana Fernández, i wsp.
Wydane: (2012)

Apoptosis Pathways in Ovarian Cancer
od: Sers, Christine, i wsp.
Wydane: (2012)

Vascular Endothelial Growth Factor (VEGF) and Epidermal Growth Factor (EGF) in Papillary Thyroid Cancer
od: Konturek, Aleksander, i wsp.
Wydane: (2012)

Clinical and laboratory significance of soluble claudin-5 and VEGF in ovarian cancer
od: N. E. Kushlinskii, i wsp.
Wydane: (2025-04-01)

Can VEGF-B Be Used to Treat Neurodegenerative Diseases?
od: Li, Xuri, i wsp.
Wydane: (2011)

MALDI-MSI and Ovarian Cancer Biomarkers
od: Longuespee, Rémi, i wsp.
Wydane: (2012)

Dysregulated TGFB Signaling in Ovarian Cancer
od: Bauckman, Kyle, i wsp.
Wydane: (2012)

Potential Tumor Biomarkers for Ovarian Cancer
od: Serio, Ryan, i wsp.
Wydane: (2012)

P53 Network in Ovarian Cancer
od: Moretti, Fabiola, i wsp.
Wydane: (2012)

Ectoenzymes in Epithelial Ovarian Carcinoma: Potential Diagnostic Markers and Therapeutic Targets
od: Buono, Nicola Lo, i wsp.
Wydane: (2012)

Nasopharyngeal Carcinoma: The Role for Chemotherapeutics and Targeted Agents
od: Knol, Jared, i wsp.
Wydane: (2012)

Role of EG-VEGF in Human Placentation: Physiological and Pathological Implications
od: Hoffmann, P., i wsp.
Wydane: (2012)

Combined Therapies to Treat CNV in AMD: PDT + Anti-VEGF
od: Mataix, Jorge, i wsp.
Wydane: (2012)

Promising Treatment Strategies for Neovascular AMD: Anti-VEGF Therapy
od: Park, Young Gun, i wsp.
Wydane: (2012)

Endometriosis-Associated Ovarian Cancer: The Role of Oxidative Stress
od: Yamashita, Yoriko, i wsp.
Wydane: (2012)

Potential Monoclonal Antibody Therapy for the Treatment of Ovarian Cancer
od: Lee, Gregory, i wsp.
Wydane: (2012)

Chemotherapy-Related Amenorrhea in Breast Cancer: Review of the Main Published Studies, Biomarkers of Ovarian Function and Mechanisms Involved in Ovarian Toxicity
od: Berliere, M., i wsp.
Wydane: (2011)

Inhibition of Tumor Growth and Metastasis by a Combination of Anti-VEGF-C and Enhanced IL-12 Therapy in an Immunocompetent Mouse Mammary Cancer Model
od: Shibata, Masa-Aki, i wsp.
Wydane: (2011)

The Role of Prophylactic Oophorectomy in the Management of Hereditary Breast & Ovarian Cancer Syndrome
od: Lowery, A.J., i wsp.
Wydane: (2012)

Photonic Sensor System for Screening Serum Biomarker Proteins in Ovarian Cancer
od: Wawro, Debra, i wsp.
Wydane: (2012)

The Role of MUC16 Mucin (CA125) in the Pathogenesis of Ovarian Cancer
od: Rancourt, Claudine, i wsp.
Wydane: (2012)

New Tumor Biomarkers in Ovarian Cancer and Its Prognostic and Clinical Relevance
od: Banys, Malgorzata, i wsp.
Wydane: (2012)

Breast and Ovarian Cancer Treatment: Facing Forward Women's Health Care
od: Herlinger, Alice Laschuk, i wsp.
Wydane: (2011)

The Different Effects of TGF-β1, VEGF and PDGF on the Remodeling of Anterior Cruciate Ligament Graft
od: Yu, Changlong, i wsp.
Wydane: (2011)

Medicinal and Edible Plants as Cancer Preventive Agents
od: Yasukawa, Ken
Wydane: (2012)

Ovarian Follicular Atresia
od: Townson, David H., i wsp.
Wydane: (2012)

ErbB2/HER2: Its Contribution to Basic Cancer Biology and the Development of Molecular Targeted Therapy
od: Yamamoto, Tadashi, i wsp.
Wydane: (2011)

Targeted Apoptosis in Breast Cancer Immunotherapy
od: Jia, Lin-Tao, i wsp.
Wydane: (2012)

New Targets for Therapy in Pancreatic Cancer
od: Tinari, Nicola, i wsp.
Wydane: (2012)

Sensitive Detection of Epithelial Ovarian Cancer Biomarkers Using Tag-Laser Induced Breakdown Spectroscopy
od: Markushin, Yuri, i wsp.
Wydane: (2012)

Transcriptomic Analysis of Human Ovarian Cancer Cells: Changes Mediated by Luteinizing Hormone Receptor Activation
od: Cui, Juan, i wsp.
Wydane: (2012)

Nanobody, New Agent for Combating Against Breast Cancer Cells
od: Rahbarizadeh, Fatemeh, i wsp.
Wydane: (2011)

Targeting Tumor Microenvironments for Cancer Prevention and Therapy
od: Yang, Li V., i wsp.
Wydane: (2012)

Molecular Targets of Benzyl Isothiocyanates in Pancreatic Cancer
od: Boreddy, Srinivas Reddy, i wsp.
Wydane: (2012)